Our group studies the synthesis of novel heterocyclic compounds such as DNA-PK, PI3K and PDE3 inhibitors for more effective treatment of cancer.
Our group use colloid chemistry to research environmental and agricultural soil systems. We also study pharmaceutical products that utilise colloidal particles and systems.
Our group have pioneered techniques to insert intramuscular electrodes into muscles at the hip and shoulder to understand the role of these muscles in the human body.
Our group examines the neurobiology and neurochemistry that underlies the physiology of metabolism.
Our group studies the use of bacteriophage as alternatives to antibiotics. We also examine the personalization of medicine to fit a patient’s genetic profile, and patient management of medication in the treatment of chronic disease.